Peer Review History
| Original SubmissionJuly 4, 2023 |
|---|
|
PONE-D-23-20755Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae), using COI and ND4 mitochondrial gene sequences.PLOS ONE Dear Dr. De Silva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please evaluate the comments made by the reviewers. The suggested changes and improvements are mandatory for future publication. Additionally, it is essential to have an assessment of the quality of the English, conducted by a native speaker of the language, to ensure understanding and clarity of the proposal. Please submit your revised manuscript by Sep 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Felipe Dutra-Rêgo, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 5. We note that Figures 1 and 2 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figures 1 and 2 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors analyzed the genetic diversity of several populations of Phlebotomus argentipes in Sri Lanka based on two well recognized mitochondrial markers. Despite not using nuclear gene markers, many specimens were sampled for mtDNA. Although the results increase knowledge about this important sand fly species, some adjustments need to be made to improve the article: i) The bibliography is out of date, some recent studies on the molecular taxonomy and populations genetics of sand flies were not included. For instance another publication on the same species and with similar objectives was recently published for Sri Lanka (https://doi.org/10.1371/journal.pone.0256819). The authors need to discuss their results in relation to this and other studies, highlighting the contributions of their findings in relation to what is already known about this species; ii) As this is a phylogeography study, it is interesting that the authors provide a phylogenetic analysis of the analyzed sequences. This helps in interpreting the results and visualizing the clustering pattern and evolutionary relationship of the sequences. I recommend using the IQTree software, which has a user-friendly webserver (http://iqtree.cibiv.univie.ac.at/); iii) Genetic structure indices (such as the Fst) can improve the understanding on the molecular divergence (or the lack of) between the analyzed populations. Other minor corrections and suggestions are in the attached pdf file. Reviewer #2: Reviewer #1: The manuscript "Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae), using COI and ND4 mitochondrial gene sequences” provides relevant information on the genetic diversity and phylogeopgraphic distribution of the sand fly Phlebotomus argentipes from Sri Lanka. In addition, it contributes to new sequences of mitochondrial markers COI and ND4 for Phlebotomus argentipes. However, some corrections/suggestions are necessary, and are detailed in the attached file. I suggested that you do a language review, there are several errors and it is not very clear in some sentences. Despite this, I considered that the authors have valuable information that can be published if they make improvements to their manuscript. Title: Lines1-3: I suggest added Phlebotominae in the title: Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae, Phlebotominae) using COI and ND4 mitochondrial gene sequences Delete the point at the end of the title. Key words: Cutaneous Leishmaniasis; Sandfly; Phlebotomus argentipes, Sri Lanka; Haplotypes, phylogeny, Do not use the same words as in the title. Find complementary words. Abstract Line 49: A total of 159 P. argentipes specimens, were collected and identified from five cutaneous leishmaniasis endemic areas. Lines 50: Cytochrome Oxidase subunit I Introduction The introduction needs to be more specific for the study area, and to the sand fly species to be analysed. There is a lot of information that is not relevant to this job. Please provide specific information (background) on the topic you are going to develop. Line 87: Out of 1,060 (Please update the number of species) sand fly species in the world, Phlebotomus argentipes Annandale and Brunetti (year???) is one of the major vectors for Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis (CL) in Sri Lanka???(or where?? specify). I share this reference where the number of species worldwide is updated: Galati E, Rodrigues B. A review of historical Phlebotominae taxonomy (Diptera: Psychodidae). Neotrop Entomol. 2023; 1–21. doi:10.1007/s13744-023-01030-8 Line 89: Being CL the most common form, annually reporting 0.7-1.2 90 million cases worldwide [4], and caused by nearly 20 species of obligate intracellular protozoa Leishmania sp. (Euglenozoa: Trypanosomatidae) [5]. I agree that cutaneous leishmaniasis is the most common clinical form worldwide. But this sentence is not so relevant in this part of the manuscript. I suggest that you to rewrite this paragraph. Lines 91-95: In Sri Lanka, around 1,991 annual CL cases have been recorded mainly in endemic areas of the North Central Province (Anuradhapura District and Polonnaruwa District) and Southern Province (Matara and Hambantota districts) in the country (Fig. 1) [6-7] Please change Figure to Fig throughout the text, considering the guidelines of the journal. Lines 98-99: are believed to be high in the country. What do you mean with “are believed”? I suggest you be more specific. Please only use facts (references) not assumptions. Line 101: host communities, host species turnover??. Do you mean to blood meal preferences with this? Line 101: vectorial capacity and competence. Do you considered the vectorial competence too?? Lines 103-105: I don’t understand why you include a map with the incidence of cutaneous leishmaniasis if your manuscript focuses on the genetic diversity of sand fly Phlebotomus argentipes? Does the distribution of Phlebotomus argentipes coincides with the sites where the cases have been reported? In this case is better including the distribution of the sand fly. I suggest that this map of cutaneous leishmaniasis cases send as supplementary information. Only include a map indicating the sites where you collected for your study (in this case the Figure 2 should be the Figure 1). Line 103: Fig 1. The distribution of… Lines 106-107: add the complete name of the genes since it is the first time they appear. [microsatellites, the Internal Transcribed Spacer 2 (ITS2)] and mitochondrial markers [cytochrome b (cytb), cytochrome oxidase subunit 1 (COI) and NADH Dehydrogenase 4 (ND4)] have been used [11-17], to determine the genetic diversity and phylogeography of different sand fly species such as P. papatasi, P. perniciosus and Lu. Longipalpis. Lines 111-112: Thus, mitochondrial genes have been used in evolutionary studies of vector species including phlebotomine sandflies. (It is necessary including a reference). Lines 112-114: However, most studies have used few mitochondrial genes to estimate the phylogeography of sand fly species. Lines 114-118: In the present study, extended fragments of the COI gene, exceeding the lengths employed in previous investigations of P. argentipes, meanwhile the ND4 fragments characterized by elevated mutation rates, were utilized to explore the phylogeography and genetic diversity of P.argentipes in Sri Lanka. Since in the previous paragraph I suggested putting the full name of the genes, in this paragraph you can abbreviated. Line 130: Material and Methods Line 132: In those study areas there were no other species of sandflies? Line 132: randomly??, Do you mean that during the three years of the sampling, you always placed the traps in different places? Please explain why were the traps not placed in the same place during sampling? What would be the explanation for the low abundance of this species during the three years of sampling? Since is a vector, I consider that for a sampling of three years, 159 specimens are very few specimens. If you collected more specimens but only used 159 for the molecular analysis, you should specify it. Lines 133-1334: from five localities in Sri Lanka from March 2018 to March 2020 (Table 1). Line 135: (Fig 2, Table 1). Line 138: for further analysis. Phlebotomus argentipes specimens… Line 140: I suggest that in Table 1 you also add the Genbank accession numbers generated in this study for COI and NAD4 genes. Line 144: Fig 2. Geographic distribution of Phlebotomus argentipes samples analysed. The sampling locations of this study are marked with a triangle, and the GenBank sequences retrieved for mitochondrial DNA fragments from Sri Lanka with a square, and those from India with a circle. I suggest that you make the letter and symbols bigger for better visualization of the figure. Line 149: How did you perform the morphological identification if you used the complete body for extraction and the head for other experiments? For the morphological identification of Phlebotomus argentipes it is not necessary to visualize the cibarium or the spermatheca? Please justify how you made the morphological identification and if you made assemblies, what technique you followed and where the specimens are kept? Line 160: Since the information that is in Table 1 is displayed in Figure 2, I consider it appropriate to join table 1 and 2 and only keep the relevant information, to avoid the information being repetitive and confusing. Only the data that you generated should be included in the table. The data that you downloaded from GenBank it is written in the paragraph (Line184-186), it is not necessary to repeat the information. Lines 173-174: The information in Table 3 can be described in the paragraph. It is not necessary the table to describe this information. Please remove the table. Line 177: specify what software you used to perform this procedure. Lines 181-182: I do not understand, what you mean with MZ882190 to MZ882255. Please be more specific, because it's confusing this way. Please do not repeat the information, is better if you refer to the table or figure. Line184-186: specify which countries the sequences are from. Results Line 195: Since I recommend removing table 3, here you can complete the information regarding the concatenated sequences. Line 209-211: Arrange the information in such a way that Table 4 remains on a single sheet. Line 212: We identified 52 haplotypes from the COI alignment and 66 for the ND4 with a range of 12-21 haplotypes per site. Lines199, 218, 223: Phlebotomus argentipes Line 231: (Fig 3) Line: 233-234: [Anuradhapura (n=10), Balangoda (n=9), Mirigama (n=5), Medirigiriya (n=6) and Hambantota (n=13)] (Fig 3). Line 234-237: It would be interesting include the mutational steps between each haplotype in the figure 3. Also indicate which haplotypes are from India and which from Sri Lanka, although the names of the localities are indicated and a color is assigned to them, it is difficult to understand what you mean with the geographical distribution does not coincide with the sampling localities. Line 238: please make the haplotype matrix bigger (Fig 3, 4 and 5). Line 250: [Anuradhapura (n=10), Balangoda (n=11), Mirigama (n=7), Medirigiriya (n=15) and Hambantota (n=12)] (Fig 4). Line 251: How did you determine that there were haplogroups? Please be more specific Line 256: I understand that you analyzed the data separately (your sequences and then the sequences of genbank). But why didn't you make a single alignment for COI? Probably some haplotypes and haplogroups are repeating if you are looking at them individually. Did you rule out that option? Line 258: I also suggest including the mutational steps in the figure 4. Line 277: Remove the references in the figure. I suggest that you explain how you obtained these haplotype networks in the material and methods section and add the references, or describe it in detail in the results. Discussion Line 290: diversity (Hd> 0.5), relatively low nucleotide diversity (π= add the value). Line 292: rather than by Indian counterparts (add the value of Hd and π for India sequences). Line 292: the fragment length used (which gene?? Both??) Line 296: [41]. Most of the findings in this study showed high Hd and low π (ii), which… Was the result something you expected? Or are other categories generally reported for the genetic diversity of the species of the genus Phlebotomus? Line 299: as shown in?? This idea seems incomplete, please redraft. The sudden population growth that you mention is due to human disturbance? P. argentipes is an anthropophilic species? Line 299-303: In the line 296-299 you explain that the haplotype diversity was high and the nucleotide diversity was low, and possibly due to sudden population growth. So why in this paragraph do you mention low genetic diversity and bottlenecks? When previously you mention the opposite? Please rearrange the information, the idea is not clear. Line 304: What are the hosts of P. argentipes?, and where are their breeding sites? Is it not an anthropophilic species of medical importance in the transmission of cutaneous leishmaniasis? Are there wild areas in the sampled areas? Line 305 …areas of higher epidemiological relevance [6], have been included in the Lines 314-315: including predefined marker systems, and PCR primers known to work for sandflies This does not seem relevant information to justify the uses of the gene ND4 is a good molecular marker. Since several genes have these characteristics, such as COI, Cytb, ITS2, 18S etc. Line 325: the remaining haplotypes were differentiated from the ancestor by one to three mutational steps. Most of the mutated haplotypes… The mutational steps data have to be included in the figures. Line 326-327: The presence of many unique haplotypes may indicate that their populations are historically established. (Add references and justify this argument better. Has this been recorded in other species of the genus? Line 327: Phlebotomus argentipes Line 330: et al. Line 339: Add references. Line 342: could not Line 345: add references Line 349: Phlebotomus argentipes Line 349-351: The distribution of Phlebotomus argentipes is restricted to India and Sri Lanka?? With the sequences that you analyzed, is it enough to conclude about the migratory history of the species? Line 352-353: This work presents new insights towards understanding the genetic diversity of P. argentipes in CL endemic areas in Sri Lanka. How??? Explain in the discussion. Reviewer #3: The study is very interesting, there are few studies conducted in that locality. However, caution should be taken regarding the true scope of the genes used. These mitochondrial markers are useful for discussing diversity and biogeography; however, they do not allow us to speak about ancestry. Other markers should be included, or the conclusions should be somewhat limited. Line 87: "The data is outdated; currently, there are 1060 sandfly species in the world (Galati, Rodriguez, 2023)." Line 95: The sentence is confusing: “Therefore, recent studies on leishmaniasis epidemiology have shown the augmentation of disease control due to a need for proper disease management practices”… maybe …."Therefore, recent studies on leishmaniasis epidemiology have shown an improvement in disease control due to the implementation of proper disease management practices." Line 152: It is important to mention the names of the primers used for PCR and the size of the amplified fragment. Line 163: The BLAST tool is used to confirm the identity of the sequence, not its origin. Line 173: It is necessary to mention the expected size of the sequence and the primers used. Generally, the fragment targeted for COI is 658 bp, but the analysis could be performed with a smaller size according to the amplified sequences. In the study, they worked with 455 bp, but the original size is not clear. Line 280: I suggest adding another reference; the cited reference only works with the Cyt b. Line 347 The conclusions go beyond the results of the study. Genetic analysis using these markers (COI and ND4) does not allow confirmation of ancestry due to the inherent nature of the marker. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-23-20755R1Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae, Phlebotominae), using COI and ND4 mitochondrial gene sequencesPLOS ONE Dear Dr. De Silva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Felipe Dutra-Rêgo, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please, check the reviewers' comments. Several minor lacunas need to be corrected prior publication. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, Thank you for providing a detailed response letter for my suggestions and comments. I have no longer major comments about your manuscript. Best regards. Reviewer #2: The manuscript "Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae, Phlebotominae), using COI and ND4 mitochondrial gene sequences” provides relevant information on the genetic diversity. I thank the authors for considering my observations and including them in their work. I extend congratulations on your research achievements. Although the article has improved a lot and I believe it can be published, some spelling errors should be corrected first by the authors. I have attached my final comments. Best regards. Line 52: delete extra parenthesis (ND4) Line 107: P. argentipes Line 127: delete extra parenthesis (ITS 2), and change parenthesis by brackets [cytochrome b (Cyt b), COI, and ND4], Line 160-161: A total of 159 specimens of P. argentipes were used for the present analysis. Line 166-167: Identified sandfly specimens were preserved in 70% ethanol before extracting DNA. Line 176: please change individuals by “specimens” Line 180-182: each primer C1J (5'- GGA GGA TTT GGA AAT TGA TTA GTT C-3') and C1N (5'- CCC GGT AAA ATT AAA ATA TAA ACT TC-3'), Line 185-186: each primer ND4ar (5’- AA(A/G) GCT CAT GTT GAA GC-3’) and ND4c (5’-ATT TAA AGG (T/C)AA TCA ATG TAA-3’), For these two comments, I suggest you put the oligos names first and then the sequence (between parentheses), as well as separate them by triplets. Line 203-204: …9,494 bp regions respectively, against the reference sequence (KR349298.1) of P. papatasi complete mitochondrial genome [39] as no P. argentipes reference sequences available in databases. Line 214-217: The unique haplotypes for the Asian region (regional analysis) were analyzed using our COI sequences and 19 COI sequences previously deposited in the GenBank repository from India [41] and Sri Lanka (KC791432 to KC791437, HQ541166, HQ585366 to HQ585373, and KT428789 to KT478792) [10]. Line 225: please change individuals by “specimens” Line 272-273: Circle size indicates the haplotype frequency, and the circle color the geographical location. Haplotype labels are written next to the corresponding circles. Line 295-296: Circle size and color indicate the frequency and geographical location of the haplotypes respectively. Haplotype labels are written next to the corresponding circles, and the red circles indicate median vectors. Line 312-315: Circle size and color indicate haplotype frequency and geographical location respectively. Haplotype labels are written next to the corresponding circles: (A) GenBank retrieved COI sequences/ regional alignment, (B) haplotypes derived from a previous study data set. Line 365-368: The study of genetic markers such as the ND4 gene has allowed for a finer resolution in the analysis of genetic variability within P. argentipes populations. Identifying numerous unique haplotypes, this research contributes to understanding the intricate genetic landscape of this sandfly species in CL endemic regions of Sri Lanka. Line 381: cryptic species Reviewer #3: Line 96 The Leishmania protozoa in their intracellular form are not considered flagellates, as the flagellum in this form is almost imperceptible; therefore, the phrase becomes confusing. I suggest replacing it with "caused by protozoan parasites of the genus Leishmania. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae, Phlebotominae), using COI and ND4 mitochondrial gene sequences PONE-D-23-20755R2 Dear Dr. De Silva, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Felipe Dutra-Rêgo, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-20755R2 PLOS ONE Dear Dr. De Silva, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Felipe Dutra-Rêgo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .